TY  - GEN
AU  - Perez de Llano, Luis Alejandro
AU  - García-Cosío, Borja
AU  - Domingo, Christian
AU  - Urrutia, Isabel
AU  - Bobolea, Irina
AU  - Valero, Antonio
AU  - Entrenas, Luis M
AU  - Quirce, Santiago
AU  - Barranco, Pilar
AU  - Marina Malanda, Nuria
AU  - Prieto Andres, Luis
AU  - Alvarez-Gutierrez, Francisco J
PY  - 2019
DO  - 10.1016/j.jaip.2019.01.017
SN  - 2213-2198
UR  - https://hdl.handle.net/20.500.12105/22687
AB  - BACKGROUND: Patients with severe allergic and eosinophilic asthma could qualify for different biologic therapies. OBJECTIVE: To evaluate the efficacy and safety of weight-based intravenous reslizumab dosing in patients who have previously failed...
LA  - eng
PB  - Elsevier
KW  - Asthma
KW  - Asthma management
KW  - Severe asthma
KW  - Omalizumab
KW  - Reslizumab
KW  - Asthma
KW  - Male
KW  - Pilot Projects
KW  - Adult
KW  - Anti-Asthmatic Agents
KW  - Female
KW  - Treatment Outcome
KW  - Humans
KW  - Antibodies, Monoclonal, Humanized
KW  - Omalizumab
KW  - Middle Aged
TI  - Efficacy and Safety of Reslizumab in Patients with Severe Asthma with Inadequate Response to Omalizumab: A Multicenter, Open-Label Pilot Study
TY  - research article
ER  -